
Annual report 2022
added 08-16-2022
Global Cord Blood Corporation Market Cap 2011-2026 | CO
As of April 07, 2026 Global Cord Blood Corporation has a market cap of $ 399 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 243 M | 486 M | 365 M | 818 M | 1.12 B | 555 M | 456 M | 460 M | 314 M | 207 M | 217 M | 236 M |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.12 B | 207 M | 456 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
42 B | $ 113.95 | -0.77 % | $ 34.6 B | ||
|
CareDx, Inc
CDNA
|
993 M | $ 17.3 | -2.92 % | $ 922 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M | ||
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
2.95 B | $ 16.4 | 0.61 % | $ 176 M | ||
|
Co-Diagnostics
CODX
|
5.85 M | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | ||
|
National Research Corporation
NRC
|
315 M | $ 17.24 | -0.52 % | $ 386 M | ||
|
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
7.69 B | $ 168.88 | 0.33 % | $ 8.37 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | ||
|
Castle Biosciences
CSTL
|
709 M | $ 24.9 | 0.67 % | $ 692 M | ||
|
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | ||
|
Biodesix
BDSX
|
92.1 M | $ 15.24 | -0.78 % | $ 1.98 B | ||
|
Koninklijke Philips N.V.
PHG
|
30.8 B | $ 26.95 | -0.97 % | $ 20 B | ||
|
Danaher Corporation
DHR
|
150 B | $ 191.24 | -0.44 % | $ 136 B | ||
|
DexCom
DXCM
|
25.5 B | $ 64.09 | 1.39 % | $ 25 B | ||
|
Fulgent Genetics
FLGT
|
467 M | $ 16.44 | 0.12 % | $ 497 M | ||
|
QIAGEN N.V.
QGEN
|
8.52 B | - | - | $ 10.6 B | ||
|
Guardant Health
GH
|
13.4 B | $ 90.19 | 0.59 % | $ 11.3 B | ||
|
Anixa Biosciences
ANIX
|
104 K | $ 2.61 | 0.77 % | $ 84.7 K | ||
|
Biomerica
BMRA
|
7.19 M | $ 2.13 | -2.07 % | $ 4.89 M | ||
|
BioNano Genomics
BNGO
|
7.95 M | $ 1.13 | -1.7 % | $ 6.15 M | ||
|
ICON Public Limited Company
ICLR
|
16.6 B | $ 108.32 | -1.18 % | $ 8.93 B | ||
|
Interpace Biosciences
IDXG
|
7.34 M | $ 1.97 | - | $ 8.72 M | ||
|
Illumina
ILMN
|
16.4 B | $ 127.78 | 0.03 % | $ 20.3 B | ||
|
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M | ||
|
Celcuity
CELC
|
5.37 B | $ 113.83 | -0.35 % | $ 5.32 B | ||
|
Laboratory Corporation of America Holdings
LH
|
23.9 B | $ 275.15 | 0.21 % | $ 22.9 B | ||
|
Lantheus Holdings
LNTH
|
5.12 B | $ 76.09 | 0.26 % | $ 5.14 B | ||
|
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
13 B | $ 497.15 | 0.23 % | $ 14.3 B | ||
|
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | ||
|
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
19.5 B | - | - | $ 19.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.3 B | $ 199.79 | 0.37 % | $ 22.2 B | ||
|
Myriad Genetics
MYGN
|
409 M | $ 4.7 | 0.64 % | $ 435 M | ||
|
ENDRA Life Sciences
NDRA
|
3.66 M | $ 4.74 | - | $ 3.73 M | ||
|
NeoGenomics
NEO
|
1.48 B | $ 8.04 | 0.25 % | $ 1.03 B | ||
|
Neogen Corporation
NEOG
|
1.02 B | $ 9.63 | 0.73 % | $ 2.09 B | ||
|
Natera
NTRA
|
5.31 B | $ 206.6 | 0.84 % | $ 20.3 B | ||
|
Pacific Biosciences of California
PACB
|
498 M | $ 1.38 | -2.82 % | $ 414 M | ||
|
Precipio
PRPO
|
38.4 M | $ 25.98 | - | $ 41.7 M | ||
|
Personalis
PSNL
|
254 M | $ 6.38 | -3.04 % | $ 378 M | ||
|
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B |